Recent Company News

• 04:13 PM ET May 28, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 07:05 AM ET May 28, 2025
  

  GSK Plc's PIVOT-PO phase III study for tebipenem HBr stops early for efficacy following review by Independent Data Monitoring Committee (1448.0000p, 0)

• 05:51 AM ET May 21, 2025
  

  Japan April estimated foreign visitor arrivals 3.9M, +28.5% y/y

• 01:06 AM ET May 09, 2025
  

  Meiji reports FY net income attributable ¥50.80B vs FactSet ¥51.67B [6 est, ¥50-54B] (¥3421.0000, -176)

• 01:36 AM ET May 01, 2025
  

  Meiji among firms considering offers for Fonterra's businesses valued at NZ$4B ($2.37B/A$3.71B/C$3.28B/¥342.03B) - Reuters (NZ$4.53, 0.00)

• 09:46 PM ET Apr 16, 2025
  

  Japan March estimated foreign visitor arrivals 3.5M, +13.5% y/y (yesterday, post Japan close)

• 10:07 PM ET Apr 07, 2025
  

  Meiji CEO/president Kazuo Kawamura to retire, effective 27-Jun (¥3312.0000, +51)

• 01:51 AM ET Mar 20, 2025
  

  Japan February estimated foreign visitor arrivals 3.3M, +16.9% y/y (19-Mar, post Japan close)

• 10:32 AM ET Mar 10, 2025
  

  StreetAccount Summary - Private company transactions for the week ended 08-Mar

• 03:54 PM ET Mar 05, 2025
  

  Meiji upgraded to equal-weight from underweight at Morgan Stanley (¥3130.0000, 0)